English
Home > Products > Iguratimod API: Therapeutic Applications, Advantages, and Limitations

China Iguratimod API: Therapeutic Applications, Advantages, and Limitations Manufacturer, Supplier, Factory

"Sincerity, Innovation, Rigorousness, and Efficiency" is the persistent conception of our company for the long-term to develop together with customers for mutual reciprocity and mutual benefit for Iguratimod API: Therapeutic Applications, Advantages, and Limitations,Introduction, In a word, when you choose us, you choose a ideal existence. Welcome to visit our factory and welcome your get! For even further inquiries, remember to usually do not hesitate to make contact with us.
Iguratimod API: Therapeutic Applications, Advantages, and Limitations, You can always find the products and solutions you need to have in our company! Welcome to inquire us about our product and anything we know and we can help in auto spare parts. We're looking forward to work with you for a win-win situation.

Related Products

Hot Products

  • Bromhexine Hydrochloride API

    Bromhexine Hydrochloride API

    Chinese product name: Bromhexine hydrochloride
    Chinese aliases: bromhexine hydrochloride; bromhexylamine hydrochloride; benzylcyclohexylamine bromide hydrochloride; 2-amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride; N- (2-Amino-3,5-dibromobenzyl)-N-methylcyclohexylamine hydrochloride;
    English product name: Bromhexine Hydrochloride API
    Cas#611-75-6
  • 4-Piperidinecarboxylic Acid

    4-Piperidinecarboxylic Acid

    Chinese product name: Locally illegal forest
    English name: 4-Piperidinecarboxylic Acid
    Cas# 1024828-77-0
    Molecular formula: C36H53N7O6
    Molecular weight: 679.85
    Appearance and properties: white to off-white solid
  • Gemcitabine T9

    Gemcitabine T9

    T9 of Gemcitabine
    Gemcitabine Intermediate 9
    Gemcitabine T9 is for intermediate for Gemcitabine Hydrochloride.
  • CAS 134790-39-9

    CAS 134790-39-9

    T9 of Gemcitabine
    Gemcitabine Intermediate 9
    CAS 134790-39-9 is for intermediate for Gemcitabine Hydrochloride.
  • CAS 122111-01-7

    CAS 122111-01-7

    Molecular formula: C19H14F2O6
    Molecular weight: 376.31
    CAS 122111-01-7 is for intermediate for Gemcitabine Hydrochloride.
  • CAS#141-86-6

    CAS#141-86-6

    Molecular formula: C5H7N3
    Molecular weight: 109.13
    CAS#141-86-6 is intermediate for hair dye products.
  • Related Blog
  • Reviews

  • What is the cost of Gemcitabine HCl T3 and is it covered by insurance?

    "What is the cost of Gemcitabine HCl T3 and is it covered by insurance?" - A brief guide to understanding the pricing and insurance coverage of Gemcitabine HCl T3.

  • What are the side effects of Rocuronium Bromide?

    Are

  • What is imidazole?

    Imidazole is a five-membered aromatic heterocyclic compound with two nitrogen atoms. The hydrogen atom moves between the two nitrogen atoms, so there are two tautomers. Imidazole not only exists in histidine in organisms, but is also a component of purine in ribonucleic acid (RNA) and deoxyribonucleic acid (DNA).

  • Why Choose 4-Nitrobenzoic Acid

    4-Nitrobenzoic Acid, a critical intermediate in pharmaceuticals, dyes, and specialty chemicals, plays a significant role in several high-value industrial sectors. With increasing demand for advanced intermediates and active pharmaceutical ingredients (APIs), understanding why 4-Nitrobenzoic Acid is so widely used has become essential for researchers, manufacturers, and distributors.

  • What is CAS NO. 288-94-8 and why should you consider it?

    ​In today's pharmaceutical and chemical manufacturing landscape, the compound identified by CAS NO. 288-94-8 plays a critical role in high-precision synthesis and functional material applications. At Jiangsu Run'an Pharmaceutical Co. Ltd., we supply this compound with a rigorous focus on quality, safety and traceability—and here is a professional overview, tailored for the purchasing, regulatory-compliance and R&D teams alike.

  • How Can Iguratimod Transform the Management of Rheumatic Diseases?

    Chronic inflammatory rheumatic disorders impose substantial burdens on patients, clinicians, and healthcare systems worldwide. As a novel disease‑modifying antirheumatic drug, Iguratimod exhibits unique anti‑inflammatory, immunomodulatory, and bone‑protective properties, providing a new therapeutic option for rheumatoid arthritis and related conditions.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept